Standard BioTools Inc. Capital Expenditures
Standard BioTools Inc. (LAB) reported Capital Expenditures of $914.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-05
- Standard BioTools Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $344.00K, a 81.77% decline year-over-year.
- Standard BioTools Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $570.00K, a 88.72% decline year-over-year.
- Standard BioTools Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $476.00K, a 85.93% decline year-over-year.
- Standard BioTools Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $886.00K, a 60.71% decline year-over-year.
- Standard BioTools Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $8.30M, a 0.62% decline from fiscal 2024.
- Standard BioTools Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $8.36M, a 195.13% increase from fiscal 2023.
- Standard BioTools Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $2.83M, a 25.99% decline from fiscal 2022.
- Standard BioTools Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $3.83M, a 71.16% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $344.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $914.00K 10-Q · filed 2026-08-05 | $1.39M derived: sum of 3 quarters · filed 2026-08-05 | $2.28M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $570.00K 10-Q · filed 2026-05-06 | $1.05M derived: sum of 2 quarters · filed 2026-05-06 | $1.93M derived: sum of 3 quarters · filed 2026-05-06 | $3.82M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $476.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $1.36M derived: sum of 2 quarters · filed 2026-03-16 | $3.25M derived: sum of 3 quarters · filed 2026-08-05 | $8.30M 10-K · filed 2026-03-16 |
| 2025-09-30 | $886.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.77M derived: sum of 2 quarters · filed 2026-08-05 | $7.83M 10-Q · filed 2025-11-04 | $11.21M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $1.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $6.94M 10-Q · filed 2026-08-05 | $10.32M derived: sum of 3 quarters · filed 2026-08-05 | $12.58M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $5.05M 10-Q · filed 2026-05-06 | $8.44M derived: sum of 2 quarters · filed 2026-05-06 | $10.69M derived: sum of 3 quarters · filed 2026-05-06 | $12.63M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $3.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $5.64M derived: sum of 2 quarters · filed 2026-03-16 | $7.57M derived: sum of 3 quarters · filed 2026-03-16 | $8.36M 10-K · filed 2026-03-16 |
| 2024-09-30 | $2.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $4.19M derived: sum of 2 quarters · filed 2025-11-04 | $4.97M 10-Q · filed 2025-11-04 | $5.05M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-06-30 | $1.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-15 | $2.72M 10-Q · filed 2025-08-15 | $2.80M derived: sum of 3 quarters · filed 2026-03-16 | $3.70M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-03-31 | $781.00K 10-Q · filed 2025-05-06 | $859.00K derived: sum of 2 quarters · filed 2026-03-16 | $1.76M derived: sum of 3 quarters · filed 2026-03-16 | $2.60M derived: sum of 4 quarters · filed 2026-03-16 |
| 2023-12-31 | $78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $983.00K derived: sum of 2 quarters · filed 2026-03-16 | $1.82M derived: sum of 3 quarters · filed 2026-03-16 | $2.83M 10-K · filed 2026-03-16 |
| 2023-09-30 | $905.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $1.74M derived: sum of 2 quarters · filed 2024-11-06 | $2.75M 10-Q · filed 2024-11-06 | $3.51M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-06-30 | $838.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $1.85M 10-Q · filed 2024-08-06 | $2.60M derived: sum of 3 quarters · filed 2025-03-11 | $3.87M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-03-31 | $1.01M 10-Q · filed 2024-05-09 | $1.76M derived: sum of 2 quarters · filed 2025-03-11 | $3.03M derived: sum of 3 quarters · filed 2025-03-11 | $3.97M derived: sum of 4 quarters · filed 2025-03-11 |
| 2022-12-31 | $755.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $2.02M derived: sum of 2 quarters · filed 2025-03-11 | $2.96M derived: sum of 3 quarters · filed 2025-03-11 | $3.83M 10-K · filed 2025-03-11 |
| 2022-09-30 | $1.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $2.20M derived: sum of 2 quarters · filed 2023-11-07 | $3.07M 10-Q · filed 2023-11-07 | $3.53M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $938.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.81M 10-Q · filed 2023-08-08 | $2.27M derived: sum of 3 quarters · filed 2023-08-08 | $3.98M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $868.00K 10-Q · filed 2023-05-09 | $1.33M derived: sum of 2 quarters · filed 2023-05-09 | $3.04M derived: sum of 3 quarters · filed 2023-05-09 | $7.21M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $463.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $2.17M derived: sum of 2 quarters · filed 2023-03-14 | $6.34M derived: sum of 3 quarters · filed 2023-03-14 | $13.26M 10-K · filed 2023-03-14 |
| 2021-09-30 | $1.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $5.88M derived: sum of 2 quarters · filed 2022-11-09 | $12.80M 10-Q · filed 2022-11-09 | $23.51M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $4.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $11.10M 10-Q · filed 2022-08-09 | $21.80M derived: sum of 3 quarters · filed 2022-08-09 | $22.14M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $6.92M 10-Q · filed 2022-05-09 | $17.63M derived: sum of 2 quarters · filed 2022-05-09 | $17.97M derived: sum of 3 quarters · filed 2022-05-09 | $18.61M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $10.71M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $11.05M derived: sum of 2 quarters · filed 2022-03-08 | $11.69M derived: sum of 3 quarters · filed 2022-03-08 | $12.72M 10-K · filed 2022-03-08 |
| 2020-09-30 | $339.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $980.00K derived: sum of 2 quarters · filed 2021-11-09 | $2.01M 10-Q · filed 2021-11-09 | $2.51M derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-06-30 | $641.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $1.67M 10-Q · filed 2021-08-06 | $2.17M derived: sum of 3 quarters · filed 2022-03-08 | $3.52M derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-03-31 | $1.03M 10-Q · filed 2021-05-07 | $1.53M derived: sum of 2 quarters · filed 2022-03-08 | $2.88M derived: sum of 3 quarters · filed 2022-03-08 | $3.29M derived: sum of 4 quarters · filed 2022-03-08 |
| 2019-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $1.85M derived: sum of 2 quarters · filed 2022-03-08 | $2.27M derived: sum of 3 quarters · filed 2022-03-08 | $2.53M 10-K · filed 2022-03-08 |
| 2019-09-30 | $1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $1.76M derived: sum of 2 quarters · filed 2020-11-09 | $2.03M 10-Q · filed 2020-11-09 | $2.05M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $419.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $685.00K 10-Q · filed 2020-08-07 | $705.00K derived: sum of 3 quarters · filed 2021-02-25 | $903.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $266.00K 10-Q · filed 2020-05-11 | $286.00K derived: sum of 2 quarters · filed 2021-02-25 | $484.00K derived: sum of 3 quarters · filed 2021-02-25 | $561.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $218.00K derived: sum of 2 quarters · filed 2021-02-25 | $295.00K derived: sum of 3 quarters · filed 2021-02-25 | $372.00K 10-K · filed 2021-02-25 |
| 2018-09-30 | $198.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $275.00K derived: sum of 2 quarters · filed 2019-11-08 | $352.00K 10-Q · filed 2019-11-08 | $530.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $77.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $154.00K 10-Q · filed 2019-08-07 | $332.00K derived: sum of 3 quarters · filed 2020-02-27 | $886.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $77.00K 10-Q · filed 2019-05-07 | $255.00K derived: sum of 2 quarters · filed 2020-02-27 | $809.00K derived: sum of 3 quarters · filed 2020-02-27 | $951.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $178.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $732.00K derived: sum of 2 quarters · filed 2020-02-27 | $874.00K derived: sum of 3 quarters · filed 2020-02-27 | $1.57M 10-K · filed 2020-02-27 |
| 2017-09-30 | $554.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $696.00K derived: sum of 2 quarters · filed 2018-11-06 | $1.39M 10-Q · filed 2018-11-06 | $2.08M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-06-30 | $142.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $834.00K 10-Q · filed 2018-08-08 | $1.53M derived: sum of 3 quarters · filed 2019-03-18 | $3.24M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-03-31 | $692.00K 10-Q · filed 2018-05-08 | $1.39M derived: sum of 2 quarters · filed 2019-03-18 | $3.10M derived: sum of 3 quarters · filed 2019-03-18 | $4.61M derived: sum of 4 quarters · filed 2019-03-18 |
| 2016-12-31 | $694.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $2.40M derived: sum of 2 quarters · filed 2019-03-18 | $3.92M derived: sum of 3 quarters · filed 2019-03-18 | $5.07M 10-K · filed 2019-03-18 |
| 2016-09-30 | $1.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $3.23M derived: sum of 2 quarters · filed 2017-11-07 | $4.37M 10-Q · filed 2017-11-07 | $5.81M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | $1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $2.66M 10-Q · filed 2017-08-08 | $4.10M derived: sum of 3 quarters · filed 2018-03-08 | $4.33M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-03-31 | $1.14M 10-Q · filed 2017-05-09 | $2.58M derived: sum of 2 quarters · filed 2018-03-08 | $2.82M derived: sum of 3 quarters · filed 2018-03-08 | $4.22M derived: sum of 4 quarters · filed 2018-03-08 |
| 2015-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $1.67M derived: sum of 2 quarters · filed 2018-03-08 | $3.07M derived: sum of 3 quarters · filed 2018-03-08 | $3.98M 10-K · filed 2018-03-08 |
| 2015-09-30 | $235.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $1.64M derived: sum of 2 quarters · filed 2016-11-09 | $2.54M 10-Q · filed 2016-11-09 | $4.03M derived: sum of 4 quarters · filed 2017-03-03 |
| 2015-06-30 | $1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $2.31M 10-Q · filed 2016-08-09 | $3.79M derived: sum of 3 quarters · filed 2017-03-03 | $5.15M derived: sum of 4 quarters · filed 2017-03-03 |
| 2015-03-31 | $909.00K 10-Q · filed 2016-05-09 | $2.39M derived: sum of 2 quarters · filed 2017-03-03 | $3.75M derived: sum of 3 quarters · filed 2017-03-03 | $6.50M derived: sum of 4 quarters · filed 2017-03-03 |
| 2014-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $2.84M derived: sum of 2 quarters · filed 2017-03-03 | $5.59M derived: sum of 3 quarters · filed 2017-03-03 | $7.40M 10-K · filed 2017-03-03 |
| 2014-09-30 | $1.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $4.11M derived: sum of 2 quarters · filed 2015-11-09 | $5.92M 10-Q · filed 2015-11-09 | $7.80M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $2.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $4.56M 10-Q · filed 2015-08-10 | $6.44M derived: sum of 3 quarters · filed 2016-02-29 | $7.10M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $1.81M 10-Q · filed 2015-05-11 | $3.69M derived: sum of 2 quarters · filed 2016-02-29 | $4.35M derived: sum of 3 quarters · filed 2016-02-29 | $4.56M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $2.53M derived: sum of 2 quarters · filed 2016-02-29 | $2.75M derived: sum of 3 quarters · filed 2016-02-29 | $3.45M 10-K · filed 2016-02-29 |
| 2013-09-30 | $653.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $867.00K derived: sum of 2 quarters · filed 2014-11-06 | $1.56M 10-Q · filed 2014-11-06 | $2.33M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | $214.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $912.00K 10-Q · filed 2014-08-04 | $1.68M derived: sum of 3 quarters · filed 2015-02-26 | $2.06M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | $698.00K 10-Q · filed 2014-05-12 | $1.46M derived: sum of 2 quarters · filed 2015-02-26 | $1.84M derived: sum of 3 quarters · filed 2015-02-26 | $2.69M derived: sum of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | $763.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $1.15M derived: sum of 2 quarters · filed 2015-02-26 | $1.99M derived: sum of 3 quarters · filed 2015-02-26 | $2.38M 10-K · filed 2015-02-26 |
| 2012-09-30 | $382.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $1.22M derived: sum of 2 quarters · filed 2013-11-07 | $1.62M 10-Q · filed 2013-11-07 | $2.30M derived: sum of 4 quarters · filed 2014-03-12 |
| 2012-06-30 | $842.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $1.24M 10-Q · filed 2013-08-07 | $1.92M derived: sum of 3 quarters · filed 2014-03-12 | $2.20M derived: sum of 4 quarters · filed 2014-03-12 |
| 2012-03-31 | $397.00K 10-Q · filed 2013-05-09 | $1.08M derived: sum of 2 quarters · filed 2014-03-12 | $1.36M derived: sum of 3 quarters · filed 2014-03-12 | $1.85M derived: sum of 4 quarters · filed 2014-03-12 |
| 2011-12-31 | $679.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-12 | $962.00K derived: sum of 2 quarters · filed 2014-03-12 | $1.46M derived: sum of 3 quarters · filed 2014-03-12 | $1.68M 10-K · filed 2014-03-12 |
| 2011-09-30 | $283.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $777.00K derived: sum of 2 quarters · filed 2012-11-09 | $997.00K 10-Q · filed 2012-11-09 | $1.41M derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-06-30 | $494.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $714.00K 10-Q · filed 2012-08-14 | $1.12M derived: sum of 3 quarters · filed 2013-03-12 | $1.59M derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-03-31 | $220.00K 10-Q · filed 2012-05-15 | $629.00K derived: sum of 2 quarters · filed 2013-03-12 | $1.10M derived: sum of 3 quarters · filed 2013-03-12 | |
| 2010-12-31 | $409.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $881.00K derived: sum of 2 quarters · filed 2013-03-12 | $1.54M 10-K · filed 2013-03-12 | |
| 2010-09-30 | $472.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $1.13M 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $658.00K 10-Q · filed 2011-08-09 | |||
| 2009-12-31 | $799.00K 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |